Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectivesSelami Demirci, John F. Tisdale, Alexis Leonard|Stem Cells Translational Medicine|2020Cited by 82
Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recoveryAlexis Leonard, John F. Tisdale, Aylin Bonifacino et al.|British Journal of Haematology|2019Cited by 75
BCL11A enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicitySelami Demirci, John F. Tisdale, Jackson Gamer et al.|Journal of Clinical Investigation|2020Cited by 67
CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and ChallengesSelami Demirci, John F. Tisdale, Alexis Leonard et al.|Advances in experimental medicine and biology|2019Cited by 62
High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2Naoya Uchida, John F. Tisdale, Tina Nassehi et al.|Molecular Therapy — Methods & Clinical Development|2019Cited by 47